Johnson & Johnson (JNJ) call put ratio 1 to 1 into EPS and outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/14/2026
- S&P 500, Dow futures dip as big banks' earnings roll in ahead of CPI data; IBM slides
- IBM plunges 19% as memory capex squeeze derails Q2 earnings
- SK Hynix’s record plunge drags down global chip stocks
- Software stocks tumble: High memory prices cannibalize enterprise tech capex
- Oil up 9% to one-month high as US says it will blockade entire Iranian coastline, all vessels
- IBM misses Q2 targets as mainframe and software sales disappoint
- Goldman Sachs Upgrades NIO (NIO) to Buy
- Wall Street ends lower as Iran tensions dampen risk appetite; chipmakers drop
- BofA Securities on AppLovin: 'Current valuation appears reasonable'
- YPF Energía Eléctrica S.A. files for proposed NYSE IPO
Johnson & Johnson (JNJ) PT Lowered to $144 at RBC Capital
January 23, 2019 6:53 AM ESTRBC Capital analyst Glenn Novarro lowered the price target on Johnson & Johnson (NYSE: JNJ) to $144.00 (from $155.00) while maintaining a Outperform rating.
Novarro notes management has set conservative 2019 guidance. As such, he expects the 'beat and raises' to continue.
... More